Reduced DAI, histology scores, and pro-inflammatory cytokines, with increased IL-13.Reduced inflammation, improved gut microbiota balance, and enriched metabolic pathways, indicating HB1628’s potential in mitigating colitis and modulating gut health. This evidence concerns the gene IL13 and colitis.